Sanofi’s North America Pharma Head Whitaker Implements Patient Solution Responses to Commercial Challenges
Since joining Sanofi as president of its North American Pharmaceuticals and Consumer Healthcare Businesses in mid-2011, Anne Whitaker has made important changes in the commercial organization to address the evolving market at a critical time for the company.
You may also be interested in...
After several years of experimentation, big pharma has settled on new commercial models for their U.S. sales teams and are in various stages of implementation, according to ZS Associates Managing Director Chris Wright. The preferred models have commonalities built around a mix of traditional sales reps, key account managers and multi-channel digital tools.
Regeneron’s five-year-old antibody partnership with Sanofi may be expensive, but it is starting to produce some interesting compounds in mid-to-late-stage clinical trials, with positive data to show.
Responding to a convergence of a changing market and shifts in technology, pharmaceutical companies are exploring ways to enhance the value of their products and find new opportunities beyond their core molecule-driven businesses.